GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XPAR:MRK) » Definitions » Investments And Advances

Merck (XPAR:MRK) Investments And Advances : €231 Mil (As of Dec. 2023)


View and export this data going back to 1946. Start your Free Trial

What is Merck Investments And Advances?

Merck's Investments And Advances for the quarter that ended in Dec. 2023 was €231 Mil.

Merck's quarterly Investments And Advances increased from Jun. 2023 (€1,121 Mil) to Sep. 2023 (€1,224 Mil) but then declined from Sep. 2023 (€1,224 Mil) to Dec. 2023 (€231 Mil).

Merck's annual Investments And Advances increased from Dec. 2021 (€327 Mil) to Dec. 2022 (€958 Mil) but then declined from Dec. 2022 (€958 Mil) to Dec. 2023 (€231 Mil).


Merck Investments And Advances Historical Data

The historical data trend for Merck's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Investments And Advances Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,322.10 645.27 327.45 958.16 231.08

Merck Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 958.16 1,204.86 1,120.52 1,223.72 231.08

Merck Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Merck (XPAR:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (XPAR:MRK) Headlines